Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
Simon Faissner(St. Josef-Hospital), Gisa Ellrichmann(Witten/Herdecke University), Carsten Lukas(University Hospitals of the Ruhr-University of Bochum), Andrew Chan(Infosys (India)), Robert Hoepner(University of Bern), Ralf Gold(St. Josef-Hospital)
Cited by 53
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706